Clinical trials
Cannabis clinical trials
Below are recruiting cannabis clinical trials, each written for real people, not researchers. We’re tracking 156 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07176208RecruitingPhase 1
THC and alcohol effects on driving in healthy adults
This study looks at how taking THC (the active ingredient in cannabis) with or without alcohol affects your driving and perception. You will take a THC pill and possibly a drink with alcohol, then have your driving tested in a simulator.
West Bend, WisconsinAges 21–55 - NCT07199218RecruitingPhase 2
Cannabis oil for autism in children aged 4 to 12
This trial tests a cannabis oil enriched with terpenes (natural compounds that may affect behavior) to see if it helps reduce severe symptoms in children with autism. It compares the oil to a placebo.
Jerusalem, N/A = Not ApplicableAges 4–13 - NCT07202351Recruiting
Sleep support for quitting smoking or cannabis
This trial tests whether adding sleep-focused help to standard quit-smoking or quit-cannabis therapy improves your chances of success. It is for people who are not already being treated for sleep problems.
Paris, Île-de-France RegionAges 18 years+ - NCT07225738Recruiting
Multiple Myeloma treatment and cannabis use study
This study follows people with newly diagnosed multiple myeloma to see how their cancer treatments and use of medications, including cannabis, affect their health. It will help doctors learn more about what works best.
Goodyear, ArizonaAges 18 years+ - NCT07225777RecruitingPhase 2
THC's effects on brain and behavior by sex
This study looks at how THC affects men and women differently, focusing on brain activity and behavior. It may help understand why some people react differently to cannabis.
Charleston, South CarolinaAges 21–45 - NCT01730781Recruiting
PET scan study to image cannabinoid receptors in the brain
This study uses a special brain scan (PET) to measure cannabinoid receptors—areas in the brain that interact with cannabis-like chemicals. It may help researchers better understand how these receptors relate to conditions such as schizophrenia, PTSD, opioid use disorder, or early psychosis risk.
New Haven, ConnecticutAges 18–55 - NCT02781519RecruitingPhase 1
Study how THC affects men and women who have used cannabis before
This Phase 1 study tests how delta-9 THC (the main active ingredient in cannabis) affects healthy adults, and whether the effects differ by gender. It may help researchers understand risks and responses to THC, which could guide safer use and future treatments.
West Haven, ConnecticutAges 18–55 - NCT02811510RecruitingPhase 1
Study of THC effects on people with past cannabis use
This Phase 1 study tests how THC (the main active ingredient in cannabis) affects healthy adults, and whether effects differ by gender. It’s designed to learn about short-term body and brain responses to THC.
West Haven, ConnecticutAges 18–55 - NCT07403266RecruitingPhase 3
Full-spectrum cannabis oil for seizures in tuberous sclerosis
This trial tests a full-spectrum cannabis extract to see if it reduces seizures in people with tuberous sclerosis complex (TSC) whose seizures have not been controlled by other treatments. If it works, it could offer a new option for managing hard-to-treat epilepsy.
MadridAges 2–65 - NCT07362407Enrolling by invitation
Cannabinoid treatment study for patients in Brazil
This study tracks how cannabis-based medicines work in real life. It looks at how people feel and function while using these treatments prescribed by their doctor.
Florianópolis, Santa CatarinaAges 18 years+ - NCT06235632Enrolling by invitation
Selling to intoxicated customers: a study for Oregon stores
This study tests ways to help marijuana and alcohol stores in Oregon sell responsibly to customers who may be intoxicated. If you work at a store, you can join to help improve safety practices.
Golden, ColoradoAges 21 years+ - NCT04812613Enrolling by invitation
Study of cannabis use and mental health support for Ottawa youth
This study looks at tobacco use alongside other addictions in young people in Ottawa who have unstable housing and mental health concerns, and who use cannabis or have used it before. It may offer support or new approaches aimed at reducing health risks related to tobacco and substance use.
Ottawa, OntarioAges 16 years+
Hear when a new Cannabis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cannabis?
- Yes. Clin2 currently lists 156 recruiting cannabis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cannabis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cannabis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.